CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 801 - 810 of 828
Study Number Lead Group Study Title CIRB Study Status
10089 ETCTN A Randomized Phase 2 Study of CDX-1127 (Varlilumab) in Combination with Nivolumab in Patients with Relapsed or Refractory Aggressive B-cell Lymphomas Adult CIRB - Early Phase Emphasis Available to Open
10076 ETCTN A Phase 1 Dose-Escalation And Exploratory Dose Expansion Study Of AMG 232 In Combination With Carfilzomib, Lenalidomide, And Dexmethasone In Relapsed And/Or Refractory Myeloma Adult CIRB - Early Phase Emphasis Available to Open
10075 ETCTN A Phase 1B Study of AMG-232 in Combination with Decitabine in Acute Myeloid Leukemia Adult CIRB - Early Phase Emphasis Available to Open
10070 ETCTN Phase 1/2 Study of Navitoclax Plus Vistusertib in Patients with Relapsed Small Cell Lung Cancer (SCLC) and Other Solid Tumors Adult CIRB - Early Phase Emphasis Available to Open
10067 ETCTN A randomized phase 2 trial of cediranib and olaparib compared to bevacizumab in patients with recurrent glioblastoma who have not received prior VEGF therapy Adult CIRB - Early Phase Emphasis Available to Open
10066 ETCTN A Phase 1 / 2 Study of Olaparib in Combination with Ramucirumab in Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma Adult CIRB - Early Phase Emphasis Available to Open
10061 ETCTN A Phase 1 Study of MK-3475 (Pembrolizumab) in Combination with Recombinant Interleukin-12 in Patients with Solid Tumors Adult CIRB - Early Phase Emphasis Available to Open
10058 ETCTN A Phase I Study of talimogene laheparepvec (TALIMOGENE LAHERPAREPVEC) with Neoadjuvant Chemotherapy and Radiation in Adenocarcinoma of the Rectum Adult CIRB - Early Phase Emphasis Available to Open
10056 ETCTN A Phase 2 Study of Talimogene Laherparepvec (T-VEC) and Radiation in Localized Soft Tissue Sarcoma Adult CIRB - Early Phase Emphasis Available to Open
10050 ETCTN A Phase II Study of Selumetinib (AZD6244) for the Treatment of Advanced Pancreas Cancer harboring KRAS G12R Mutations Adult CIRB - Early Phase Emphasis Completed
Displaying 801 - 810 of 828